Viz.ai Appoints Radiology Advisory Board
Viz.ai Appoints Radiology Advisory Board mbarbella@rodmanmedia.com (Michael Barbella)
Viz.ai has created a Radiology Advisory Board to help the company develop strategy and products to support radiologists and patients. The Board consists of 14 healthcare experts with diverse experience and roles in radiology.
“The deep expertise of our board will propel Viz.ai to new heights by driving the development of products that will support radiologists in their work and enhance patient outcomes,” Viz.ai Chief Clinical Officer Jayme Strauss said. “We are grateful for the expertise, time, and support of our board members and proud to partner with them on this important endeavor.”
The board will assist Viz.ai's team in informing its radiology strategy and research and development activities. Members will assess the impact of the Viz radiology program, identify clinical need for new features and modes of implementation, verify effectiveness of new capabilities, and ensure that sound scientific evidence supports projects. Additionally, the board will provide strategic advice regarding emerging science and therapeutic trends.
“I’m looking forward to working with these esteemed board members to help shape Viz.ai’s Radiology Program through patient-centric vision, passion, and insights” said Suzie Bash, M.D., co-chair of the Viz.ai Radiology Advisory Board and medical director of Neuroradiology at San Fernando Valley Interventional Radiology at RADNET. “The role of artificial intelligence in radiology is growing exponentially. I’m excited by the opportunity that this foundational group of radiology experts has to apply translational, clinical AI experience to improve patient outcomes.”
The board's other co-chair is Kevin Abrams, M.D., medical director of neuroradiology and MRI and chief of radiology at Baptist Hospital in Miami. “I am honored to co-chair the Radiology Advisory Board and excited about Viz.ai’s commitment to customers and patients to invest in innovation that increases access to life-saving therapies. I am looking forward to the rich dialogue to be discussed in our inaugural meeting, exploring future ideas,” he said.
Viz.ai develops AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 200 million lives across 1,200-plus hospitals and health systems in the United States and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by clinical data, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies.